1,784
Participants
Start Date
August 9, 2025
Primary Completion Date
May 1, 2026
Study Completion Date
July 1, 2026
5μg/ml EEC
0.1ml, one time, containing high dose 5μg/ml of active ingredients
5 unit（U） EC
0.1 ml , one time, containing 5U of active ingredients
5 IU TB-PPD
0.1 ml , one time, containing 5IU of active ingredients
IGRA
96-well/plate x 2 plates; 100 tubes/box x 1 box
RECRUITING
Beijing Chest Hospital, Beijing
RECRUITING
Changsha Center Hospital, Hunan
RECRUITING
Wuhan Pulmonary Hospital, Wuhan
RECRUITING
Public health clinical center of chengdu, Chengdu
RECRUITING
LiuZhou People's Hospital, Liuzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang
RECRUITING
Wuhan Central Hospital, Wuhan
RECRUITING
Yichang Central People's Hospital, Yichang
Beijing Chest Hospital, Capital Medical University
OTHER
Wuhan Pulmonary Hospital
OTHER
Changsha Central Hospital
OTHER
The First Affiliated Hospital of Xinxiang Medical College
OTHER
LiuZhou People's Hospital
OTHER
Wuhan Central Hospital
OTHER
Yichang Central People's Hospital
OTHER
Chengdu CoenBiotech Co., Ltd
INDUSTRY